National & Regional Leaders in Non-Muscle Invasive Bladder Cancer Care
At Conrad Pearson, we are committed to providing advanced, patient-centered care for individuals diagnosed with bladder cancer. Through the Conrad Pearson Bladder Cancer Center of Excellence, patients gain access to experienced specialists, innovative treatment options, leading-edge clinical research, and compassionate support throughout every step of their journey.
Our team has a particular focus on the diagnosis, treatment, and management of Non-Muscle Invasive Bladder Cancer (NMIBC), offering access to some of the newest therapies and clinical trial opportunities available today.
Bladder Cancer: The Sixth Most Common Cancer in the United States
Bladder cancer is one of the most common cancers diagnosed in both men and women. While it is more common in men, anyone can develop bladder cancer, making awareness and early evaluation critically important.
Risk Factors for Bladder Cancer
Several factors can increase your risk of developing bladder cancer, including:
- Smoking and tobacco use
- Exposure to certain workplace chemicals
- Increasing age
- Chronic bladder inflammation
- Family history of bladder cancer
- Previous cancer treatments involving radiation or chemotherapy
Signs and Symptoms to Watch For
The most common symptom of bladder cancer is blood in the urine (hematuria). Blood may be visible to the naked eye or only detected during testing.
Other symptoms may include:
- Frequent urination
- Pain or burning during urination
- Urgency to urinate
- Pelvic discomfort
If you experience blood in your urine, it is important to seek prompt evaluation from a urologist.
Have You Been Diagnosed with Bladder Cancer?
Not all bladder cancers are the same. Understanding your diagnosis is important because treatment options can vary significantly depending on the stage and extent of the disease.
Non-Muscle Invasive Bladder Cancer (NMIBC)
Approximately 70% of newly diagnosed bladder cancers are classified as Non-Muscle Invasive Bladder Cancer. This means the cancer is confined to the inner lining of the bladder and has not spread into the bladder muscle.
While NMIBC can often be treated successfully, it requires careful monitoring because it can recur over time. Patients with NMIBC may benefit from specialized treatments, advanced therapies, and access to clinical research opportunities.
Muscle-Invasive Bladder Cancer (MIBC)
Muscle-invasive bladder cancer occurs when the cancer has grown into the muscle layer of the bladder wall. This type of bladder cancer often requires a different treatment approach and may involve surgery, chemotherapy, radiation therapy, or a combination of treatments.
The Conrad Pearson Bladder Cancer Center of Excellence focuses primarily on the management of Non-Muscle Invasive Bladder Cancer and helping patients access the most advanced therapies available.
Conrad Pearson Expertise in Bladder Cancer
Patients across the country and throughout the Mid-South trust Conrad Pearson Clinic as nationally and regionally recognized leaders in bladder cancer diagnosis, treatment, and long-term management. Our team combines advanced clinical expertise, innovative treatment options, and a commitment to delivering personalized, high-quality care for every patient.
The Conrad Pearson Bladder Cancer Center of Excellence is led by Dr. Ravi Chauhan, a board-certified urologist and nationally recognized expert in urologic oncology. Dr. Chauhan specializes in the treatment of advanced bladder and kidney cancer and is actively involved in advancing care through research, innovation, and clinical trials. His focus is on improving outcomes, reducing recurrence risk, and ensuring patients have access to the most advanced treatment options available.
Through our Advanced Bladder and Kidney Cancer Program, we bring together the full range of resources needed to support patients at every stage of disease. This includes advanced risk assessment, individualized treatment planning, and access to emerging therapies and clinical trials for eligible patients.
Our multidisciplinary approach ensures each patient receives care tailored to their diagnosis, goals, and lifestyle—whether that includes minimally invasive tumor removal, intravesical therapy, immunotherapy, or long-term surveillance designed to reduce recurrence.
At Conrad Pearson, patients benefit from:
- Nationally and regionally recognized expertise in Non-Muscle Invasive Bladder Cancer (NMIBC)
- Leadership in bladder cancer research and clinical trials
- Access to advanced therapies and emerging treatment options
- Comprehensive, personalized treatment planning
- Long-term surveillance and recurrence prevention strategies
- Coordinated, patient-centered care from a dedicated urologic oncology team
Our physicians remain at the forefront of bladder cancer innovation, helping ensure patients receive the most advanced, evidence-based care available both regionally and nationwide.
The Importance of a Second Opinion for Bladder Cancer
A bladder cancer diagnosis can feel overwhelming, and treatment decisions are often complex.
Seeking a second opinion can help you:
- Better understand your diagnosis
- Confirm your treatment plan
- Explore additional treatment options
- Learn about clinical trial opportunities
- Gain confidence in your next steps
Even when a second opinion confirms your original recommendation, many patients find reassurance in knowing they have explored all available options.
At Conrad Pearson, our bladder cancer specialists are available to review your diagnosis, pathology reports, imaging studies, and treatment recommendations to help you make informed decisions about your care.
Access to the Most Advanced Treatments for Non-Muscle Invasive Bladder Cancer
Treatment for Non-Muscle Invasive Bladder Cancer (NMIBC) depends on several factors, including the stage, grade, and risk level of the disease. At Conrad Pearson, we develop personalized treatment plans designed to help reduce recurrence, preserve bladder function, and achieve the best possible outcomes.
Advanced Therapies and Emerging Treatment Options
Bladder cancer treatment is evolving rapidly, giving patients more options than ever before to preserve their bladder while effectively treating cancer. At Conrad Pearson, we offer many of the latest advanced therapies for non-muscle invasive bladder cancer (NMIBC),
including innovative treatments such as Adstiladrin® gene therapy, Anktiva®, Keytruda®, and emerging technologies like, Zusduri and INLEXO, sustained-release treatment delivery systems.
As one of the region’s leaders in urologic cancer research, Conrad Pearson offers eligible patients access to clinical trials evaluating promising new therapies and treatment approaches and patients may have opportunities to receive innovative treatments that are not yet widely available.
Our team continually evaluates the latest advancements in bladder cancer care to ensure patients have access to the most current treatment options available.
Patient Testimonial
I have been cancer free for over twenty years….. I am so thankful The Conrad Pearson Clinic. In my opinion they rank EXCELLENT and have a genuine concern for their patients. They are accurate on diagnosis and relentless in finding the best treatment available. The staff is friendly and professional.
I highly recommend The Conrad Pearson Clinic.
— Ken
Request a Second Opinion
If you have been diagnosed with Non-Muscle Invasive Bladder Cancer, our team is here to help.
Whether you are newly diagnosed, considering treatment options, or seeking access to advanced therapies and clinical trials, Conrad Pearson can provide expert guidance and personalized recommendations.
